KFF COVID-19 Vaccine Monitor: In Their Own Words
The KFF COVID-19 Vaccine Monitor conducted interviews with a nationally representative sample of 1,009 adults, using open-ended questions to better…
The KFF COVID-19 Vaccine Monitor conducted interviews with a nationally representative sample of 1,009 adults, using open-ended questions to better…
As the country broadens COVID-19 vaccine distribution efforts, the latest research from the KFF COVID-19 Vaccine Monitor finds that side…
Introduction There are currently two COVID-19 vaccines authorized for use in the United States, both of which require a two-dose…
This data note analyzes federal Medicaid outlays before and during the COVID-19 pandemic. In federal fiscal year 2020 (FFY 2020),…
KFF is collecting and analyzing data on COVID-19 vaccinations by race/ethnicity to gain increased insight into who is receiving the…
Four million uninsured people could get an ACA bronze plan with no premium payment and 4.9 million others could get…
The Biden Administration has announced that the ACA Marketplaces will re-open for a special enrollment period (SEP) from February 15…
Ensuring racial and ethnic diversity in clinical trials for development of COVID-19 vaccines is particularly important since COVID-19 has taken…
Here’s our recap of the past week in the coronavirus pandemic from our tracking, policy analysis, polling, and journalism. This week marked the one-year…
While older Americans are a high-priority group for getting a COVID-19 vaccine, the latest KFF COVID-19 Vaccine Monitor report finds that, among…